Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cells|June 2, 2021
CDK4/6 Inhibitors in Melanoma: A Comprehensive ReviewMattia Garutti, Giada Targato, Silvia Buriolla, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the LiteratureGiada Targato, Lucia Bortot, Arianna Dri, et al.
Frontiers in Oncology|June 24, 2022
Multidisciplinary Approach to Patients With Metastatic Spinal Cord Compression: A Diagnostic Therapeutic Algorithm to Improve the Neurological OutcomeRossella Rispoli, Chiara Reverberi, Giada Targato, et al.
International Journal of Molecular Sciences|July 9, 2022
Immunotherapy in NSCLC Patients with Brain MetastasesSilvia Buriolla, Giacomo Pelizzari, Carla Corvaja, et al.
Cancers|January 11, 2024
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational StudyGiulia Ottaviani, Giada Targato, Katia Rupel, et al.
The Oncologist|February 4, 2021
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 PandemicGianpiero Fasola, Giacomo Pelizzari, Diego Zara, et al.
Journal of Neurology|February 20, 2021
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)Veronica Villani, Elena Anghileri, Luca Prosperini, et al.
Frontiers in Oncology|October 19, 2020
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast CancerLorenzo Gerratana, Debora Basile, Alessandra Franzoni, et al.
Frontiers in Oncology|June 24, 2022
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?Lucia Bortot, Giada Targato, Claudia Noto, et al.
The Oncologist|March 23, 2024
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-WorldGiulia Pasello, Martina Lorenzi, Daniela Scattolin, et al.
Pageof 2